AVEO Oncology to Present at the Barclays Global Healthcare Conference Business Wire CAMBRIDGE, Mass. -- March 6, 2013 AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Barclays Global Healthcare Conference on Wednesday, March 13, 2013 at 9:00 a.m. (ET) in Miami. A live webcast of AVEO’s presentation can be accessed by visiting the investors section of the company’s website at investor.aveooncology.com. A replay of the webcast will be archived on the AVEO website for two weeks following the presentation. About AVEO AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives. AVEO’s proprietary Human Response Platform^TM provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the company’s website at www.aveooncology.com. Contact: Pure Communications Investor Contact: Caton Morris, 910-232-7166 or AVEO Oncology Media Contact: Rob Kloppenburg, 617-930-5595
AVEO Oncology to Present at the Barclays Global Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.